Recovering Antibody Secretion Using a Hapten Ligand as a Chemical Chaperone

Gregory D. Wiens, Thomas O'Hare, Marvin Rittenberg

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Engineered antibodies have come to the forefront as research reagents and clinical therapeutics. However, reduced stability or expression levels pose a major problem with many engineered antibodies. As a model for understanding functional consequences of variable region mutation, we have studied the assembly and trafficking of anti-phenylphosphocholine antibodies. Previously, we identified severe secretion defects because of mutations in the heavy chain second complementarity determining region, which is involved in antigen binding. Here we demonstrate that immunoglobulin secretion is increased up to 27-fold by incubating stably transfected PCG1-1 cells with cognate hapten p-nitrophenylphosphocholine. Secretion was unaffected by nonbinding analogs. Radiotracer and metabolic labeling experiments demonstrated specific cellular uptake of p-nitrophenylphosphocholine and increased intracellular heavy and light chain assembly. Brefeldin A inhibited hapten-mediated immunoglobulin secretion but not assembly, indicating that assembly occurs early within the biosynthetic pathway. Recovery of secretion correlated with antigen binding capacity, suggesting that the rescue mechanism involves stabilization of heavy and light chain variable domains. This model system provides the first demonstration that cognate ligands can increase intracellular assembly of functional anti-hapten antibody within mammalian cells and suggests that small molecules of appropriate specificity and affinity acting as chemical chaperones may find application for increasing or regulating immunoglobulin expression.

Original languageEnglish (US)
Pages (from-to)40933-40939
Number of pages7
JournalJournal of Biological Chemistry
Volume276
Issue number44
DOIs
StatePublished - Nov 2 2001

Fingerprint

Haptens
Immunoglobulins
Ligands
Antibodies
Anti-Idiotypic Antibodies
Complementarity Determining Regions
Brefeldin A
Light
Antigens
Mutation
Biosynthetic Pathways
Labeling
Research
Demonstrations
Stabilization
Cells
Recovery
Defects
Molecules
4-nitrophenylphosphocholine

ASJC Scopus subject areas

  • Biochemistry

Cite this

Recovering Antibody Secretion Using a Hapten Ligand as a Chemical Chaperone. / Wiens, Gregory D.; O'Hare, Thomas; Rittenberg, Marvin.

In: Journal of Biological Chemistry, Vol. 276, No. 44, 02.11.2001, p. 40933-40939.

Research output: Contribution to journalArticle

Wiens, Gregory D. ; O'Hare, Thomas ; Rittenberg, Marvin. / Recovering Antibody Secretion Using a Hapten Ligand as a Chemical Chaperone. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 44. pp. 40933-40939.
@article{4b2366655910454ea2edb2ae0be6b06d,
title = "Recovering Antibody Secretion Using a Hapten Ligand as a Chemical Chaperone",
abstract = "Engineered antibodies have come to the forefront as research reagents and clinical therapeutics. However, reduced stability or expression levels pose a major problem with many engineered antibodies. As a model for understanding functional consequences of variable region mutation, we have studied the assembly and trafficking of anti-phenylphosphocholine antibodies. Previously, we identified severe secretion defects because of mutations in the heavy chain second complementarity determining region, which is involved in antigen binding. Here we demonstrate that immunoglobulin secretion is increased up to 27-fold by incubating stably transfected PCG1-1 cells with cognate hapten p-nitrophenylphosphocholine. Secretion was unaffected by nonbinding analogs. Radiotracer and metabolic labeling experiments demonstrated specific cellular uptake of p-nitrophenylphosphocholine and increased intracellular heavy and light chain assembly. Brefeldin A inhibited hapten-mediated immunoglobulin secretion but not assembly, indicating that assembly occurs early within the biosynthetic pathway. Recovery of secretion correlated with antigen binding capacity, suggesting that the rescue mechanism involves stabilization of heavy and light chain variable domains. This model system provides the first demonstration that cognate ligands can increase intracellular assembly of functional anti-hapten antibody within mammalian cells and suggests that small molecules of appropriate specificity and affinity acting as chemical chaperones may find application for increasing or regulating immunoglobulin expression.",
author = "Wiens, {Gregory D.} and Thomas O'Hare and Marvin Rittenberg",
year = "2001",
month = "11",
day = "2",
doi = "10.1074/jbc.M104979200",
language = "English (US)",
volume = "276",
pages = "40933--40939",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "44",

}

TY - JOUR

T1 - Recovering Antibody Secretion Using a Hapten Ligand as a Chemical Chaperone

AU - Wiens, Gregory D.

AU - O'Hare, Thomas

AU - Rittenberg, Marvin

PY - 2001/11/2

Y1 - 2001/11/2

N2 - Engineered antibodies have come to the forefront as research reagents and clinical therapeutics. However, reduced stability or expression levels pose a major problem with many engineered antibodies. As a model for understanding functional consequences of variable region mutation, we have studied the assembly and trafficking of anti-phenylphosphocholine antibodies. Previously, we identified severe secretion defects because of mutations in the heavy chain second complementarity determining region, which is involved in antigen binding. Here we demonstrate that immunoglobulin secretion is increased up to 27-fold by incubating stably transfected PCG1-1 cells with cognate hapten p-nitrophenylphosphocholine. Secretion was unaffected by nonbinding analogs. Radiotracer and metabolic labeling experiments demonstrated specific cellular uptake of p-nitrophenylphosphocholine and increased intracellular heavy and light chain assembly. Brefeldin A inhibited hapten-mediated immunoglobulin secretion but not assembly, indicating that assembly occurs early within the biosynthetic pathway. Recovery of secretion correlated with antigen binding capacity, suggesting that the rescue mechanism involves stabilization of heavy and light chain variable domains. This model system provides the first demonstration that cognate ligands can increase intracellular assembly of functional anti-hapten antibody within mammalian cells and suggests that small molecules of appropriate specificity and affinity acting as chemical chaperones may find application for increasing or regulating immunoglobulin expression.

AB - Engineered antibodies have come to the forefront as research reagents and clinical therapeutics. However, reduced stability or expression levels pose a major problem with many engineered antibodies. As a model for understanding functional consequences of variable region mutation, we have studied the assembly and trafficking of anti-phenylphosphocholine antibodies. Previously, we identified severe secretion defects because of mutations in the heavy chain second complementarity determining region, which is involved in antigen binding. Here we demonstrate that immunoglobulin secretion is increased up to 27-fold by incubating stably transfected PCG1-1 cells with cognate hapten p-nitrophenylphosphocholine. Secretion was unaffected by nonbinding analogs. Radiotracer and metabolic labeling experiments demonstrated specific cellular uptake of p-nitrophenylphosphocholine and increased intracellular heavy and light chain assembly. Brefeldin A inhibited hapten-mediated immunoglobulin secretion but not assembly, indicating that assembly occurs early within the biosynthetic pathway. Recovery of secretion correlated with antigen binding capacity, suggesting that the rescue mechanism involves stabilization of heavy and light chain variable domains. This model system provides the first demonstration that cognate ligands can increase intracellular assembly of functional anti-hapten antibody within mammalian cells and suggests that small molecules of appropriate specificity and affinity acting as chemical chaperones may find application for increasing or regulating immunoglobulin expression.

UR - http://www.scopus.com/inward/record.url?scp=0035798549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035798549&partnerID=8YFLogxK

U2 - 10.1074/jbc.M104979200

DO - 10.1074/jbc.M104979200

M3 - Article

C2 - 11533029

AN - SCOPUS:0035798549

VL - 276

SP - 40933

EP - 40939

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 44

ER -